In a more specific analysis circulating levels of intact SDF-1α increased while levels of truncated (DPP4-cleaved) SDF-1α decreased both in T2D patients using sitagliptin (64, 65) and in animals with gliptin administration (66). Here, CXCL12 is linked to type 2 diabetes mellitus.